InterCure Ltd.

Tel Aviv Stock Exchange INCR.TA

InterCure Ltd. Goodwill for the year ending December 31, 2023: USD 60.89 M

InterCure Ltd. Goodwill is USD 60.89 M for the year ending December 31, 2023, a -24.60% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

InterCure Ltd. Goodwill for the year ending December 31, 2022 was USD 80.76 M, a -2.76% change year over year.
InterCure Ltd. Goodwill for the year ending December 31, 2021 was USD 83.05 M, a 40.47% change year over year.
InterCure Ltd. Goodwill for the year ending December 31, 2020 was USD 59.13 M, a 21.79% change year over year.
InterCure Ltd. Goodwill for the year ending December 31, 2019 was USD 48.55 M.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Tel Aviv Stock Exchange: INCR.TA

InterCure Ltd.

CEO	Mr. Alexander Rabinovich
IPO Date	Sept. 9, 2007
Location	Israel
Headquarters	85 Medinat ha-Yehudim Street
Employees	270
Sector	Consumers Staples
Industries Tobacco Alcoholic Beverages Biotechnology Bread & Bakery Cosmetics Personal Care Pharmaceuticals

Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Key trends

Past 5 years